Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Medtronic
Cantor Fitzgerald
McKesson
Colorcon
Citi

Generated: August 22, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Ozanimod

  Try a free trial


See Plans and Pricing

« Back to Dashboard

US Patents for Ozanimod

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ozanimod ➤ Sign Up Kinase inhibitors Respivert Limited (High Wycombe, Buckinghamshire, GB) Topivert Pharma Limited (London, GB) ➤ Sign Up
Ozanimod ➤ Sign Up Kinase inhibitors Respivert Limited (N/A) Topivert Pharma Limited (London, GB) ➤ Sign Up
Ozanimod ➤ Sign Up Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis CELGENE INTERNATIONAL II S RL (Couvet, CH) ➤ Sign Up
Ozanimod ➤ Sign Up Sphingosine pathway modulating compounds for the treatment of cancers Enzo Biochem, Inc. (New York, NY) ➤ Sign Up
Ozanimod ➤ Sign Up Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis Receptos, Inc. (San Diego, CA) ➤ Sign Up
Ozanimod ➤ Sign Up Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis Celgene International II Sarl (Couvet, CH) ➤ Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Subscribe to access the full database, or try a Free Trial

International Patents for Ozanimod

Drugname Country Document Number Estimated Expiration Related US Patent
Ozanimod Australia 2017245888 2036-04-06 ➤ Sign Up
Ozanimod Brazil 112018067552 2036-04-06 ➤ Sign Up
Ozanimod Canada 3015978 2036-04-06 ➤ Sign Up
Ozanimod China 109071505 2036-04-06 ➤ Sign Up
Ozanimod European Patent Office 3440073 2036-04-06 ➤ Sign Up
Ozanimod South Korea 20180133250 2036-04-06 ➤ Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Argus Health
Federal Trade Commission
Teva
QuintilesIMS
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.